Personalis, Inc.

Industry

  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
    • Saliva-based Testing
  • Research, Analytical Equipment & Supplies
  • Services
  • Digital Health
    • Disease Management
  • Pharmaceuticals
See more in Biomedtracker

Latest on Personalis, Inc.

In Vivo

Dealmaking Quarterly Statistics, Q4 2024

 
• By Maureen Riordan and Deanna Kamienski

Biopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr

In Vivo

Device/Diagnostics Quarterly Deal Statistics, Q1 2015

 
• By Maureen Riordan and Amanda Micklus

Device Transactions Device financing reached $934 million during 2015's first quarter, a slight increase over Q4's $902 million. ( See Exhibit 1. ) Representing 37% of the financing total, follow-on p

Scrip

Start-Up Quarterly Statistics, Q1 2015

 
• By Deanna Kamienski

Financings During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion

Scrip

Venture Funding Deals, February 2015

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS Assurex Health Inc. Personalized CNS medicine company Assurex raises $30mm in Series D round New backers American Financial Group and Cross Creek Advisors joined returning sha